Forward P/S Multiple: InspireMD (NSPR)

InspireMD, Inc. - graphic logo of issuer NSPR

InspireMD, Inc. (NSPR) is driving margin growth by scaling the production of titanium meshes for stroke prevention. The forward P/S ratio on the GURU.Markets daily chart reflects this trend, where 3.30 is the current value of the metric. However, geopolitical tensions are hindering chip deliveries and system certifications, while the company's narrow business profile is offset by the exclusive status of its technologies in Europe and the US.

inspiremd.com - NSPR Market Cap to Projected Revenue (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for InspireMD Inc. (NSPR)

- market price and analyst price targets:
Price Chart InspireMD|NSPR - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization InspireMD Inc.|NSPR - Total Enterprise Value
- issuer book value statistics:
Book Value per Share InspireMD|NSPR - Accounting Capitalization|Market Capitalization to Book Value Ratio inspiremd.com|NSPR - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital InspireMD, Inc.|NSPR - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital InspireMD, Inc.|NSPR - Company Aggregate Debts|Debt to Book Capitalization Ratio InspireMD Inc.|NSPR - Company Long-Term Debt|Company Current Liabilities InspireMD|Quick Ratio inspiremd.com
- financial results and valuation multiples details:
NSPR - Company Net Income|Expected Profit InspireMD, Inc.|NSPR - Market Cap to Net Income Ratio|Projected Price to Earnings InspireMD Corp|NSPR - PEG Multiple|EV/EBITDA Multiple InspireMD Inc.|NSPR - Operating income before deduction of amortization|Earnings per share for the last twelve months InspireMD|NSPR - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months inspiremd.com|NSPR - Net earnings per share growth this year|Earnings growth forecast for next year InspireMD, Inc.
- sales and revenue indicators:
NSPR - Company Total Revenue|Company Projected Revenue InspireMD|NSPR - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple InspireMD Inc.
Fundamental company analysis:NSPR (InspireMD)
Product sample of InspireMD Inc.

To minimize the risk of overpaying, it is essential for investors to track market capitalization dynamics relative to projected revenue. The expected P/S ratio allows for a real-time assessment of the value of future flows, which is critical for InspireMD, Inc. (NSPR) as it transitions to automated flaw detection and scales its software, since any adjustments to production robotization plans are immediately reflected on this chart.

Who InspireMD, Inc. competes with

Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|ALGN (Align Technology) - Forward P/S Multiple|Globus Medical Inc (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Corp ATEC|Forward P/S Multiple AORT (Artivion, Inc.)|Forward P/S Multiple enovis.com ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Corp) - Forward Price-to-Revenue Multiple|IRADIMED Inc. - Forward Price to Sales|EMBC (Embecta Corp.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio tandemdiabetes.com TNDM|Price-to-Projected Revenue Ratio Axogen (AXGN)|SI-BONE Inc (SIBN) - Projected Price to Revenue|Orthofix International - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bioventus Global BVS|OrthoPediatrics Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio treace.com TMCI|Strata Critical Medical (SRTA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CARL (Carlsmed, Inc.)|Price-to-Projected Revenue Ratio RxSight Corp|Forward Price-to-Revenue Multiple ClearPoint (CLPT)|Forward P/S Multiple STXS|STIM - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Sight Sciences SGHT|OBIO: Market Cap to Projected Revenue|ANIK: Forward Price-to-Revenue Multiple|Jin Medical International - Price to Expected Revenue Ratio|VANI: Forward P/S Multiple|XTNT - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio NeuroOne Medical Technologies Corporation|Market Cap to Projected Revenue MODD (Modular Med)|Price-to-Projected Revenue Ratio Myomo, Inc (MYO)|Market Cap to Expected Sales Ratio Envoy Medical Inc|Price-to-Projected Revenue Ratio Vivos Therapeutics VVOS|NVNO (envveno.com) - Future Price to Revenue|SINTX Technologies - Forward P/S Multiple|Market Cap to Expected Sales Ratio Tenon Medical Inc. TNON|ReWalk Robotics Ltd (LFWD) - Price-to-Projected Revenue Ratio|Autonomix Medical - Forward Price to Sales|IVF (INVO Fertility Inc) - Forward P/S Multiple|Market Cap to Future Revenue Ratio bonebiologics.com BBLG|Price-to-Projected Revenue Ratio Axonics (AXNX)|Forward Price-to-Revenue Multiple BIOLASE Inc. BIOL|Forward P/S Multiple DYNT (Dynatronics)|FNA: Market Cap to Projected Revenue|INVO: Forward Price-to-Revenue Multiple